Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors
published in: Melanoma Research
date of publication: 2020-04-01
main subject: acute kidney injury, pembrolizumab, rapid evolution
Cites articles
There is nothing here
Article - wd:Q90846977